证券记录 · 已归档季度
IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
19被追踪持有人
-1Δ持有人
19.49M持有股份
$4.61B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -5.0% ·
股份流向 -9.7% ·
净新建仓位 -5.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 166 | +9 | 123.07M | $23.74B | +12 | −2 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | — |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | — | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | — |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | — | 21.58M | $4.56B | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 10.18M | -4.6% | $2.41B | 4.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (被动) | 4.10M | -3.0% | $967.59M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (被动) | 1.69M | +4.1% | $399.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Capital World Investors ✦ | 666.69K | +0.1% | $157.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Marshall Wace ✦ | 514.64K | +563.1% | $121.96M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 413.01K | -28.8% | $97.87M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 387.05K | +19.5% | $91.72M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 341.24K | +159.9% | $80.86M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | PRIMECAP Management ✦ | 325.96K | +0.2% | $77.24M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 310.15K | +15.5% | $73.50M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 189.65K | +109.1% | $44.47M | 0.1% | ▲ Add | 2 | SEC ↗ ×4 |
| 12 | Citadel Advisors ✦ | 139.52K | -55.4% | $33.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 63.60K | -81.0% | $15.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Markel Group ✦ | 58.73K | 0.0% | $13.92M | 0.1% | Held | 2 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 48.26K | 新增 | $11.44M | 0.0% | New | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 28.06K | -14.4% | $6.65M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 23.73K | -85.9% | $5.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Wellington Management ✦ | 8.69K | -99.5% | $2.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 19 | Fisher Asset Management ✦ | 7.40K | +4.8% | $1.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $11.44M | 0.0% |
已清仓
| Duquesne Family Office | $12.76M | 曾为 0.5% |
| Bridgewater Associates | $204,674 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,061 持有人, 150.48M 股份, $24.99B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
Berkshire James G.
Officer · 2.67K 股 · $697,228
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据